These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 23859703)
1. Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study. Modaresi SM; Ejtemaei Mehr S; Faramarzi MA; Esmaeilzadeh Gharehdaghi E; Azarnia M; Modarressi MH; Baharifar H; Vaez SJ; Amani A Pharm Dev Technol; 2014 Aug; 19(5):593-7. PubMed ID: 23859703 [TBL] [Abstract][Full Text] [Related]
2. Optimization of Self-Assembled Chitosan/Streptokinase Nanoparticles and Evaluation of Their Cytotoxicity and Thrombolytic Activity. Baharifar H; Tavoosidana G; Karimi R; Bidgoli SA; Ghanbari H; Faramarzi MA; Amani A J Nanosci Nanotechnol; 2015 Dec; 15(12):10127-33. PubMed ID: 26682458 [TBL] [Abstract][Full Text] [Related]
3. On-Chip Preparation of Streptokinase Entrapped in Chitosan Nanoparticles Used in Thrombolytic Therapy Potentially. Shamsi M; Zahedi P J Pharm Sci; 2017 Dec; 106(12):3623-3630. PubMed ID: 28826879 [TBL] [Abstract][Full Text] [Related]
4. Prolonged systemic delivery of streptokinase using liposome. Kim IS; Choi HG; Choi HS; Kim BK; Kim CK Arch Pharm Res; 1998 Jun; 21(3):248-52. PubMed ID: 9875439 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584 [TBL] [Abstract][Full Text] [Related]
7. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
8. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin. Peng Q; Sun X; Gong T; Wu CY; Zhang T; Tan J; Zhang ZR Acta Biomater; 2013 Feb; 9(2):5063-9. PubMed ID: 23036950 [TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization. Yu JM; Li YJ; Qiu LY; Jin Y J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361 [TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Zhang J; Chen XG; Li YY; Liu CS Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086 [TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles for ocular delivery of cyclosporine A. Başaran E; Yenilmez E; Berkman MS; Büyükköroğlu G; Yazan Y J Microencapsul; 2014; 31(1):49-57. PubMed ID: 23834316 [TBL] [Abstract][Full Text] [Related]
12. Preparation of PEG-grafted chitosan/streptokinase nanoparticles to improve biological half-life and reduce immunogenicity of the enzyme. Baharifar H; Khoobi M; Arbabi Bidgoli S; Amani A Int J Biol Macromol; 2020 Jan; 143():181-189. PubMed ID: 31758987 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808 [TBL] [Abstract][Full Text] [Related]
14. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
15. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation. Shahbazi MA; Hamidi M; Mohammadi-Samani S J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580 [TBL] [Abstract][Full Text] [Related]
16. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems. Liu P; Zhao X Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Chronopoulou L; Massimi M; Giardi MF; Cametti C; Devirgiliis LC; Dentini M; Palocci C Colloids Surf B Biointerfaces; 2013 Mar; 103():310-7. PubMed ID: 23261553 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
20. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]